Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas

Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas

Relevance. Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of aggressive lymphoproliferative malignancies that account for approximately 10% of adult non-Hodgkins lymphomas. Despite the variety of PTCL subtypes, CHOP-like regimens are the standard first-line therapy in most cases....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina V. Poddubnaya, Elena A. Bariakh, Sergei V. Voloshin, Liliia G. Gorenkova, Kamil D. Kaplanov, Alla M. Kovrigina, Nataliia B. Mikhailova, Tatiana I. Pospelova, Vadim V. Ptushkin, Gaiane S. Tumian, Natalia A. Falaleeva, Gulnara N. Khusainova
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
cd30-positive peripheral t-cell lymphomas
brentuximab vedotin
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/fe0771127994485f9b77da21b6852fed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fe0771127994485f9b77da21b6852fed

Ejemplares similares